Literature DB >> 10877965

Pharmacokinetics and penetration of danofloxacin into the gastrointestinal tract in healthy and in Salmonella typhimurium infected pigs.

R H Lindecrona1, C Friis, J P Nielsen.   

Abstract

The pharmacokinetics and penetration of danofloxacin into the gastrointestinal tract in healthy pigs and in pigs experimentally infected with Salmonella typhimurium were studied. In the infected pigs, a decrease in body clearance and an increase in mean elimination half-life was observed (P < 0.01). Moreover a significant reduction in the volume of the peripheral compartment was found. Danofloxacin distributed well to the gastrointestinal tract achieving high AUC / AUC(plasma)ratios in both groups of pigs. However, compared to the healthy pigs AUC / AUC(plasma)ratios decreased in the infected pigs. Salmonella infection led to an increase in mean residence time (MRT) in the small intestines and lymph nodes and a decrease in MRT in caecum and colon. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10877965     DOI: 10.1053/rvsc.1999.0361

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  11 in total

1.  Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters.

Authors:  J A Schrickx; J Fink-Gremmels
Journal:  Br J Pharmacol       Date:  2007-01-08       Impact factor: 8.739

Review 2.  Veterinary Medicine Needs New Green Antimicrobial Drugs.

Authors:  Pierre-Louis Toutain; Aude A Ferran; Alain Bousquet-Melou; Ludovic Pelligand; Peter Lees
Journal:  Front Microbiol       Date:  2016-08-03       Impact factor: 5.640

3.  Pharmacokinetic and Pharmacodynamic Integration and Modeling of Enrofloxacin in Swine for Escherichia coli.

Authors:  Jianyi Wang; Haihong Hao; Lingli Huang; Zhenli Liu; Dongmei Chen; Zonghui Yuan
Journal:  Front Microbiol       Date:  2016-02-02       Impact factor: 5.640

4.  Pharmacokinetics of tilmicosin in healthy pigs and in pigs experimentally infected with Haemophilus parasuis.

Authors:  Ling Zhang; Li Zhao; Yonghong Liu; Junfeng Liu; Xianqiang Li
Journal:  J Vet Sci       Date:  2017-12-31       Impact factor: 1.672

5.  The effects of different enrofloxacin dosages on clinical efficacy and resistance development in chickens experimentally infected with Salmonella Typhimurium.

Authors:  Jun Li; Haihong Hao; Guyue Cheng; Xu Wang; Saeed Ahmed; Muhammad Abu Bakr Shabbir; Zhenli Liu; Menghong Dai; Zonghui Yuan
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

6.  Pharmacokinetics and pharmacodynamics integration of danofloxacin against Eschrichia coli in piglet ileum ultrafiltration probe model.

Authors:  Yuqi Yang; Ping Cheng; Tianshi Xiao; Jargalsaikhan Ulziikhutag; Hongxiao Yu; Jiarui Li; Ruimeng Liu; Ishfaq Muhammad; Xiuying Zhang
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

7.  Effects of danofloxacin dosing regimen on gastrointestinal pharmacokinetics and fecal microbiome in steers.

Authors:  J L Halleran; B J Callahan; M E Jacob; H J Sylvester; T Prange; M G Papich; D M Foster
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

8.  Distribution of Flumequine in Intestinal Contents and Colon Tissue in Pigs after Its Therapeutic Use in the Drinking Water.

Authors:  Jose M Rodríguez; M Jose Diez; Matilde Sierra; Juan J Garcia; Nelida Fernandez; Raquel Diez; Ana M Sahagun
Journal:  Animals (Basel)       Date:  2021-05-23       Impact factor: 2.752

9.  Abcb1 in Pigs: Molecular cloning, tissues distribution, functional analysis, and its effect on pharmacokinetics of enrofloxacin.

Authors:  Tingting Guo; Jinhu Huang; Hongyu Zhang; Lingling Dong; Dawei Guo; Li Guo; Fang He; Zohaib Ahmed Bhutto; Liping Wang
Journal:  Sci Rep       Date:  2016-08-30       Impact factor: 4.379

10.  Dosing Regimen of Enrofloxacin Impacts Intestinal Pharmacokinetics and the Fecal Microbiota in Steers.

Authors:  Kaitlyn M Ferguson; Megan E Jacob; Casey M Theriot; Benjamin J Callahan; Timo Prange; Mark G Papich; Derek M Foster
Journal:  Front Microbiol       Date:  2018-09-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.